• <em>PPE</em> Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Côte d'Ivoire
• A <em>Mycobacterium ulcerans</em> vaccine pilot trial using an accurate low-dose challenge
• A Bibliometric Study on Buruli Ulcer Based on the Web of Science Database
• A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strain
• A lesion in two: Buruli ulcer and squamous cell carcinoma coexistence
• A single synthetic lipid antigen for improved serological diagnosis of Buruli ulcer
• Accelerating the healing of hard-to-heal wounds with food supplements: nutritional analysis in the Côte d'Ivoire
• Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer
• Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans
• An evaluation of mental health integration in the neglected tropical diseases program in Zamfara, North-west Nigeria
• An mHealth App (eSkinHealth) for Detecting and Managing Skin Diseases in Resource-Limited Settings: Mixed Methods Pilot Study
• An Overview of 10 Years of Activity of a Molecular Laboratory for Buruli Ulcer Diagnosis at a Field Hospital in Benin
• Appraising perception, accessibility and uptake of DAT among patients with TB
• Assessing the cost-effectiveness of integrated case management of Neglected Tropical Diseases in Liberia
• Bacillus Calmette Guerin
• Bacterial diversity in Buruli ulcer lesions in Ghana
• Behavioral interplay between mosquito and mycolactone produced by Mycobacterium ulcerans and bacterial gene expression induced by mosquito proximity
• Buruli ulcer - A neglected tropical disease in the Barwon region of Victoria, Australia: An emerging public health threat with local and national ramifications
• Buruli ulcer in Africa: Geographical distribution, ecology, risk factors, diagnosis, and indigenous plant treatment options - A comprehensive review
• Buruli ulcer with satellite lesions: A case report from Japan
• Buruli ulcer, tuberculosis and leprosy: Exploring the One Health dimensions of three most prevalent mycobacterial diseases: A narrative review
• Buruli ulcer: application of thermography for remote diagnosis of a neglected tropical disease
• Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in <em>Mycobacterium</em><em>ulcerans</em> disease, a protocol for a randomised controlled trial in Ghana
• Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacteriumulcerans disease, a protocol for a randomised controlled trial in Ghana
• Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria
• Changes in Inflammatory Markers in Patients Treated for Buruli Ulcer and Their Ability to Predict Paradoxical Reactions
• Clinical and microbiological predictors of healing in Buruli ulcer disease
• Community based integrated wound care: Results of a pilot formative research conducted in Benin and Côte d'Ivoire, West Africa
• Comprehensive Case-Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia
• Deep learning for AI-based diagnosis of skin-related neglected tropical diseases: A pilot study
• Effectiveness of Using AI-Driven Hotspot Mapping for Active Case Finding of Tuberculosis in Southwestern Nigeria
• Emergence and spread of <em>Mycobacterium ulcerans</em> at different geographic scales
• Endemic infectious cutaneous ulcers syndrome in the Oti Region of Ghana: Study of cutaneous leishmaniasis, yaws and Haemophilus ducreyi cutaneous ulcers
• Evaluation of an electricity-independent method for IS2404 Loop-mediated isothermal amplification (LAMP) diagnosis of Buruli ulcer in resource-limited settings
• Evaluation of In2Care mosquito stations for suppression of the Australian backyard mosquito, Aedes notoscriptus (Diptera: Culicidae)
• Extensive buruli ulcer in a patient returning from Mali and Senegal
• Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature
• Floristic Diversity as an Indicator in Low and High Endemic Buruli Ulcer Areas in Cote d'Ivoire
• From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone
• Health-Seeking Behavior Regarding Coughs in Urban Slums in Lagos, Nigeria
• How our molecular understanding of the pathogenesis of <em>Mycobacterium ulcerans</em> infection can improve diagnosis of Buruli ulcer
• How our molecular understanding of the pathogenesis of Mycobacterium ulcerans infection can improve diagnosis of Buruli ulcer
• Immune Targeting of Mycobacteria through Cell Surface Glycan Engineering
• Impact of COVID-19 on the neglected tropical diseases: a scoping review
• Impact of the Stool-Based Xpert Test on Childhood Tuberculosis Diagnosis in Selected States in Nigeria
• Implementation of an integrated control programme for neglected tropical diseases of the skin in Ghana: The essential role of the laboratory
• Implementing patient-public engagement for improved health: Lessons from three Ghanaian community-based programmes
• Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin
• Imported Buruli ulcer-is there risk for travellers?
• Improving TB Case Detection Through Active Case-Finding: Results of Multiple Intervention Strategies in Hard-to-Reach Riverine Areas of Southern Nigeria
• Improving TB control: efficiencies of case-finding interventions in Nigeria
• Inflammasome-triggered IL-18 controls skin inflammation in the progression of Buruli ulcer
• Influence of the new dispersible fixed-dose combination anti-Tuberculosis drug on treatment adherence among children with Tuberculosis in Osun State, Nigeria
• Is BCG vaccination of possums the solution to the Buruli ulcer epidemic in south-eastern Australia?
• Key Contributions by the Swiss Tropical and Public Health Institute Towards New and Better Drugs for Tropical Diseases
• Memory B-cells are enriched in the blood of patients with acute Buruli ulcer disease: a prospective observational study
• Mental health, stigma and the quality of life of people affected by neglected tropical diseases of the skin in Kasai Province, Democratic Republic of the Congo: a sex-disaggregated analysis
• Mosquitoes as Vectors of Mycobacterium ulcerans Based on Analysis of Notifications of Alphavirus Infection and Buruli Ulcer, Victoria, Australia
• Mosquitoes provide a transmission route between possums and humans for Buruli ulcer in southeastern Australia
• Mosquitoes spread the Buruli ulcer agent Mycobacterium ulcerans
• Multi-centric evaluation of Biomeme Franklin Mobile qPCR for rapid detection of Mycobacterium ulcerans in clinical specimens
• Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against <em>Mycobacterium ulcerans</em>
• Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient
• Multisensory medical illustrations of Buruli ulcer for improved disease detection, help seeking behaviour and adherence to treatment
• Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model
• Mycobacterium ulcerans culture results according to duration of prior antibiotic treatment: A cohort study
• Mycobacterium ulcerans not detected by PCR on human skin in Buruli ulcer endemic areas of south eastern Australia
• Mycobacterium ulcerans-Bordetella trematum chronic tropical cutaneous ulcer: A four-case series, Cote d'Ivoire
• Mycolactone A vs. B: Does localization or association explain isomer-specific toxicity?
• Mycolactone A vs. B: Multiscale Simulations Reveal the Roles of Localization and Association in Isomer-Specific Toxicity
• Neglected tropical diseases in Republic of Guinea: disease endemicity, case burden and the road towards the 2030 target
• Overview of infectious and non-infectious diseases in French Guiana in 2022
• Perception, acceptability and challenges of digital adherence technology among TB healthcare workers
• Pilot use of a mycolactone-specific lateral flow assay for Buruli ulcer: A case report from Japan
• PPE Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Cote d'Ivoire
• Prevalence and risk factors associated with Haemophilus ducreyi cutaneous ulcers in Cameroon
• Pseudogenomic insights into the evolution of Mycobacterium ulcerans
• Publisher Correction: Mosquitoes provide a transmission route between possums and humans for Buruli ulcer in southeastern Australia
• Qualitative study of the stigma associated with the lived experiences of Buruli ulcer disease among patients in Nigeria
• Recent Advances in the Management Strategies for Buruli Ulcers
• Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against <em>Mycobacterium ulcerans</em>
• Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
• Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease
• Research article network analysis of polymicrobial chronic wound infections in Masanga, Sierra Leone
• Severe cases of Buruli ulcer (infection with Mycobacterium ulcerans) in common ringtail possums in Victoria adversely affect animal welfare
• Stigma experiences, effects and coping among individuals affected by Buruli ulcer and yaws in Ghana
• Systematic review: Global host range, case fatality and detection rates of <em>Mycobacterium ulcerans</em> in humans and potential environmental sources
• The current status of neglected tropical diseases in Japan: A scoping review
• The development, implementation, and evaluation of an optimal model for the case detection, referral, and case management of Neglected Tropical Diseases
• The effect of the Covid-19 pandemic on Tuberculosis (TB) case notification in Ogun State, Nigeria
• The Many Hosts of Mycobacteria 9 (MHM9): A conference report
• The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use
• The psychosocial impacts of skin-neglected tropical diseases (SNTDs) as perceived by the affected persons: A systematic review
• The role of economic factors in shaping and constituting the household burden of neglected tropical diseases of the skin: Qualitative findings from Ghana and Ethiopia
• Traditional healers' perception on scabies causation and management in Ghana
• Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles
• Understanding the burden of poor mental health and wellbeing among persons affected by leprosy or Buruli ulcer in Nigeria: A community based cross-sectional study
• Unlocking Opportunities for <em>Mycobacterium leprae</em> and <em>Mycobacterium ulcerans</em>
• Using Passive Surveillance to Maintain Elimination as a Public Health Problem for Neglected Tropical Diseases: A Model-Based Exploration
• What about Current Diversity of Mycolactone-Producing Mycobacteria? Implication for the Diagnosis and Treatment of Buruli Ulcer